It is a rather glossy affair. Comprises: front inside and outside cover, four interior pages and rear inside and outside cover. All printed on impressive heavy card stock. It is substantially focused on Ganetespib,
In VERY large print the cover states:
“ Hsp90 Inhibition”
Inside more than half the President’s letter is taken up with Ganetespib (Hsp90).
Of the remaining three interior pages all of two are totally occupied about Ganetespib (Hsp90).
This does not sound like to me that SNTA is on the eve of reporting disappointing Ganetespib (Galaxy) trial results.
In this litigious age -- one does not go out that far on a branch like this -- unless one is quite sure the wood is good.